Cell-Type-Specific Translation Profiling Reveals a Novel Strategy for Treating Fragile X Syndrome. (2017)
Attributed to:
Targeting ERK and mTOR for the treatment of fragile X syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.neuron.2017.07.013
PubMed Identifier: 28772121
Publication URI: http://europepmc.org/abstract/MED/28772121
Type: Journal Article/Review
Volume: 95
Parent Publication: Neuron
Issue: 3
ISSN: 0896-6273